Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial
Preprint in medRxiv (September 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Preprint in medRxiv (September 2024)
Article in Cancer Treatment Reviews (May 2024)
Article in Frontiers in Oncology (January 2024)